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The TRPC2 channel forms protein-protein
interactions with Homer and RTP in the rat
vomeronasal organ
Research article

Thomas G Mast1,2, Jessica H Brann1,2,4 and Debra A Fadool*1,2,3

Abstract
Background: The signal transduction cascade operational in the vomeronasal organ (VNO) of the olfactory system
detects odorants important for prey localization, mating, and social recognition. While the protein machinery
transducing these external cues has been individually well characterized, little attention has been paid to the role of
protein-protein interactions among these molecules. Development of an in vitro expression system for the transient
receptor potential 2 channel (TRPC2), which establishes the first electrical signal in the pheromone transduction
pathway, led to the discovery of two protein partners that couple with the channel in the native VNO.
Results: Homer family proteins were expressed in both male and female adult VNO, particularly Homer 1b/c and
Homer 3. In addition to this family of scaffolding proteins, the chaperones receptor transporting protein 1 (RTP1) and
receptor expression enhancing protein 1 (REEP1) were also expressed. RTP1 was localized broadly across the VNO
sensory epithelium, goblet cells, and the soft palate. Both Homer and RTP1 formed protein-protein interactions with
TRPC2 in native reciprocal pull-down assays and RTP1 increased surface expression of TRPC2 in in vitro assays. The
RTP1-dependent TRPC2 surface expression was paralleled with an increase in ATP-stimulated whole-cell current in an
in vitro patch-clamp electrophysiological assay.
Conclusions: TRPC2 expression and channel activity is regulated by chaperone- and scaffolding-associated proteins,
which could modulate the transduction of chemosignals. The developed in vitro expression system, as described here,
will be advantageous for detailed investigations into TRPC2 channel activity and cell signalling, for a channel protein
that was traditionally difficult to physiologically assess.
Background
The mammalian accessory olfactory system (AOS) functions as a detector for chemical signals (chemosignals)
concerning social organization and conspecific reproductive status [1,2]. The vomeronasal organ (VNO) is the primary sensory organ for the AOS. In rodents, the VNO is
an encapsulated neuroepithelium containing a lumen and
is able to aspirate fluids via a vascular pump [3,4]. Vomeronasal sensory neurons (VSN) express vomeronasal
receptors (VRs) belonging to one of the two families of Gprotein coupled receptors (GPCRs) specific to the VNO,
the V1Rs and V2Rs [5-7]. Upon binding of a chemosignal,
V1Rs and V2Rs activate the G-proteins, Gαi2 and Gαo,
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respectively [1]. G-protein activation can ultimately
result in a non-specific cation current through the canonical transient receptor potential channel type 2 (TRPC2)
[8-10].
VNO function is dependent upon TRPC2 [11-13].
Adaptor proteins scaffold TRPC to proteins such as inositol 1,4,5-trisphosphate receptor type 3 (IP3R3) [14-16].
In the invertebrate retina TRP is in a scaffold-mediated
complex whereby deletion of the scaffold leads to complex degradation and altered light responses [17]. The
TRP channel and IP3 receptor are co-localized in VSN
microvilli [18] whereby peptide disruption of the proteinprotein interaction between them inhibits chemosignalinduced currents [14].
Homers are adaptor proteins that bind to proline-rich
sequences on proteins associated with calcium signalling

Full list of author information is available at the end of the article
© 2010 Mast et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons

BioMed Central Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.

Mast et al. BMC Neuroscience 2010, 11:61
http://www.biomedcentral.com/1471-2202/11/61

[19]. Long Homer isoforms (1b/c, 2a/b, 3) contain,
whereby the immediate-early gene encoded short isoform
(1a) lacks, a coiled-coil motif that mediates multimerization [19,20]. Homers alter the function and distribution
of metabotropic glutamate receptors (mGluRs) [20-22].
TRPC2 clones have poor surface expression in vitro and
may require a chaperone for proper formation [23,24].
Receptor transporting protein 1 (RTP1) and receptor
expression enhancing protein 1 (REEP1) are putative
transmembrane protein chaperones expressed in the
main olfactory system, which target olfactory GPCRs to
the membrane and form protein-protein interactions
with olfactory GPCRs in vitro [25]. RTP1 and REEP1
mRNAs are expressed in the mouse VNO, but as of yet,
neither protein has been reported in VSNs, and have not
been proposed to have any functional interactions with
vomeronasal GPCRs [25].
Given the role of TRPC2 in chemosignal detection, the
interactions of TRPC2 with adaptor proteins in other
sensory systems, and chaperone mRNA expression in the
VNO, we sought to test the hypothesis that TRPC2 forms
protein-protein associations with partners that could
alter channel function or localization. Specifically, we
sought to identify interactions between TRPC2 and
Homer family members and interactions between TRPC2
and RTP1 or REEP1. First, we demonstrate VNO protein
expression of RTP1, Homer, and TRPC2. Next we
describe novel, in vivo, interactions between TRPC2 and
Homer 1b/c as well as TRPC2 and RTP1. Lastly, we demonstrate a physiological role for the interaction between
RTP1 and TRPC2; in vitro co-expression of RTP1 with
TRPC2 leads to increased cell-surface expression of functional TRPC2.

Results
Homer, RTP1, and REEP1 are Expressed in the Vomeronasal
Organ

TRPC2 forms a protein-protein interaction with IP3R3 in
rat VSNs [18] and a peptide blocker of this interaction
functionally reduces odor-activated currents [14]. We
therefore questioned whether adaptor proteins might
moderate the scaffold complex. Rat VNO tissue was
screened with an antiserum that recognized all homer
isoforms (Pan-Homer). Pan-Homer antiserum was
observed to label proteins at the predicted molecular
weight via SDS-PAGE followed by Western analysis on
NP40-solubilized tissue extracts from the hippocampus
(H), cerebellum (Ce), cerebral hemisphere (CH), olfactory
bulb (OB), and vomeronasal organ (VNO) (Fig. 1A). Only
long forms (Mr = 45 kDa) were detected using the panHomer antiserum, presumably because the short form of
Homer (H1a) is a transient product of an activity-dependent immediate early gene [20], making detection difficult. The commercial pan-Homer antiserum (Fig. 1A),

Page 2 of 16

and not the investigator-generated antisera (Fig. 1B-E)
(see methods), produced a non-selective band at 50 kDa,
and therefore was not utilized in subsequent biochemical
analyses.
Isoform-specific antisera were then utilized to further
probe which Homer isoforms were predominantly found
in the VNO. Homer 1b/c and Homer 3 were expressed in
all neural tissues tested including the OB and the VNO
(Figs. 1B and 1E). Repetition of SDS-PAGE and Western
analysis using the same tissue extracts as in Fig. 1B
resulted in no immunoreactive labelling with preimmune
serum used to generate the homer 1b/c antiserum (Fig.
1C). Homer 2 was weakly detected in the VNO, but was
found in the OB, as well as other brain regions tested (Fig.
1D). In our previous studies we have noted sexual dimorphism in the VNO [26,27], therefore, male and female
VNO lysates were separately probed with Homer antisera. An appreciable sex difference was not consistently
detected (Figs. 1A-E). Equal protein loading was confirmed for all Western blots by stripping the blot and then
re-probing for actin immunoreactivity (i.e. Additional
File 1, Fig. S1).
RTP1 and REEP1 mRNAs have only been demonstrated in the mouse [25], therefore rat VNO cDNA was
screened using gene-specific primers and reverse-transcriptase PCR (RT-PCR) for chaperone expression. RTP1
and REEP1 expression in the rat VNO is reported in Fig.
1F. Each RT-PCR reaction produced a single band and
the identity of the band was confirmed by sequencing. An
additional screening of RTP1 in the mouse main olfactory
epithelium was also performed across various postnatal
stages as reported in Additional File 1, Fig. S1.
Since RTP1 cellular localization has not been previously explored in the olfactory system, the determination
of the cells or cellular processes that express RTP1 was
made using immunoctyochemistry (ICC). Coronal sections of the rat nasal cavity containing both the vomeronasal and the main olfactory epithelium (MOE) were
incubated with an antiserum for RTP1 (Fig. 2). Using an
avidin-peroxidase chromagen method, putative RTP1
immunoreactivity was evident in the rat MOE cilia (osn;
Fig. 2A), VNO microvilli (vsn; Fig. 2B), goblet cells (gob;
Fig. 2B), and the soft palate (sp; Fig. 2B). Higher resolution micrographs of the MOE cilia and VNO microvilli
can be seen in Figs. 2C and 2E, respectively. RTP1 immunoreactivity was absent from all other structures including the respiratory epithelium (res; Fig. 2D) and from the
VNO microvilli that were processed without primary
antiserum (Fig. 2F). To determine whether the labelling of
RTP1 might overlap with previous TRPC2 microvillar
localization reported by our laboratory and others [8,18]
we used dual-colored ICC with fluorescently-tagged secondary antisera to test for co-localization of TRPC2 and
RTP1. As shown in Figs. 2G-I, the signals for the two pro-
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Figure 1 Adaptor protein expression in the rat vomeronasal organ (VNO). (A-E) Representative Western blots of NP40-solubilized proteins incubated with Homer family antisera as labeled. Proteins were separated by SDS-PAGE and then electro-transferred to nitrocellulose as described in the
text. Expected Mr = 45/47, 29 kDa. Abbreviations: H = hippocampus, VNO = vomeronasal organ, OB = olfactory bulb, Ce = cerebellum, CH = cerebral
hemispheres, T = testis, M = male, F = female. Representative of 3-4 individual preparations for each antiserum. (F) Two representative trials of RT-PCR
products specific for RTP1 (RTP) and REEP1 (REEP), respectively. The expected PCR products were 597 bp (RTP1) and 623 bp (REEP1). CON = no reverse
transcriptase negative control.

teins extensively overlap at the microvilli (m) as evidenced in the merged image overlay (Fig. 2I). Omission of
primary antisera eliminated the fluorescent signal in each
condition tested (Figs. 2J-L). As an additional control for
RTP1 antiserum specificity, human embryonic kidney
293 (HEK293) cells were transfected with an RTP1
expression vector and then processed under non-permeabilizing conditions for RTP1 immunoreactivity. Preincubating the cells with proteinase K abolished the RTP1
immunoreactivity (Additional File 1, Fig. S1B, C).
Homer and RTP1 form protein-protein interaction with
TRPC2

Previous in vitro data have demonstrated that TRPC2 and
Homer 1 form a protein-protein interaction [16]. Our
discovered co-localization of TRPC2 and RTP1 suggests
that these proteins may also bind in vivo. To test the rigor

of potential protein-protein interactions, reciprocal coimmunoprecipitations were performed in native rat VNO
lysates (Fig. 3). TRPC2 was clearly immunoprecipitated
with both Homer 1b/c (Figs. 3C and 3D) and RTP1 (Figs.
3E and 3F). Interestingly, Homer 1b/c could co-immunoprecipitate with both IP3R3 (Fig. 3A and 3B) and TRPC2.
Additional negative controls using rabbit sera as the first
source for immunoglobulins failed to produce bands at
the expected molecular weight (Additional File 1, Fig.
S1D). Protein interactions with REEP1 could not be
investigated due a lack of available antiserum.
TRPC2 transfection efficiency in a heterologous expression
system

Due to the reported increased surface expression of olfactory receptors by the chaperone RTP1 [25] and our dis-
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Figure 2 TRPC2/RTP1 co-localization in the rat nasal cavity. Sixteen micron coronal sections were processed for αRTP1 immunocytochemistry using an avidin-peroxidase chromagen method (A-F) or dual-colored immunocytochemistry with fluorescent secondary antisera (G-L). Low-power
magnification of the (A) main olfactory epithelium (MOE) and (B) vomeronasal epithelium. osn = olfactory sensory neuron, res = respiratory epithelium,
vsn = vomeronasal sensory neuron, gob = goblet cells, sp = soft palate. Higher-power magnification reveals αRTP1 labelling in the cilia layer of the
MOE (inset C) and microvilli layer of the VNO (inset E) but absence of label in the respiratory cilia (inset D). Control VNO section with omission of primary
antiserum (F). Higher-power magnification of the VNO (G-L), αRTP1 (G), αTRPC2 (H), merged image (I). Control sequential sections to that of G-I with
omission of the primary antisera (J-L). Scale bar 25 μm (C-F) or 100 μm (A, B, G-L). Scale bar in J is the same for G-L. Italicized lettering in boxes is linked
to enlarged image sub-panel. m = microvillar layer.
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Figure 3 TRPC2 co-immunoprecipitates with IP3R3, Homer 1b/c,
and RTP1 in the rat VNO. For each condition the antiserum used for
immunoprecipitation (IP) was added to the VNO lysates, IP proteins
were separated by SDS-PAGE and then probed (Blot) with an antiserum against the suspected protein partner. Data are representative for
3-5 individual preparations. Expected Mr = TRPC2 97, IP3R3 >220, Homer 1b/c 45 kDa, as indicated. (A) Homer 1b/c co-immunoprecipitated
with IP3R3. (B) The reverse co-immunoprecipitation of A. (C) Homer 1b/
c co-immunoprecipitated with TRPC2. (D) The reverse co-immunoprecipitation of C. (E) RTP1 co-immunoprecipitated with TRPC2. (F) The reverse co-immunoprecipitation of E. IgG = the heavy chain of the
immunoglobin G.

covery of its interaction and cellular co-localization with
TRPC2, we hypothesized that the chaperone would
increase the surface expression of TRPC2. To test this,
TRPC2 was expressed with or without either RTP1 or
REEP1 in HEK293 cells. Transfected cells were incubated
with an antiserum for the myc-epitope tag on the plasmid-encoded TRPC2 and then visualized using a speciesspecific FITC-conjugated secondary antiserum. A representative field of view used to calculate the transfection
efficiency for various transfection conditions is shown in
Fig. 4. The ratio of fluorescent cells (left column, Figs. 4A,
C, E, and 4G) over that of all cells (right column, Figs. 4B,
D, F, and 4H; DAPI nuclear stain) was used to calculate

Figure 4 TRPC2 transfection efficiency in HEK293 cells. (A-H) Representative micrographs of cells grown on glass-coverslips, transfected
as in text, incubated with an antiserum to the c-myc epitope and labeled with FITC-conjugated secondary antiserum. (A, C, E, and G) Representative fields of view for antiserum specific fluorescence (green).
(B, D, F, and H) The same fields of view as in images B, D, F, and H with
DAPI nuclear stain (blue). Note the low percentage of cells transfected
in (A, B) TRPC2, (C, D) TRPC2 + RTP1, (E, F) TRPC2 + REEP1, as compared
to (G, H) Kv1.3. The scale bar in G is 100 μm. (I) Histogram plot of the
ratio of transfected cells. The number of quantified transfections are
noted. * = denotes a mean pixel density significantly different from
Kv1.3 transfection; one-way ANOVA followed by a snk post-hoc test (p
≤ 0.05).
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way ANOVA followed by a Student Newman-Keuls (snk)
post-hoc test (F = 4.01, p < 0.05). Neither cells transfected
with empty vector nor those labelled without the primary
antiserum were immunoreactive (data not shown).
RTP1 alters the subcellular localization of TRPC2 in vitro

RTP1 and REEP1 are able to induce membrane expression of olfactory receptors in HEK293 [25]. Therefore, we

Figure 5 Subcellular localization of TRPC2 in HEK293 cells. (A-E)
Representative two-photon confocal micrographs of cells grown,
transfected, and immunolabeled as in Fig. 4. Note that TRPC2 immunoreactivity in (A) appears subcellular while that of Kv1.3 immunoreactivity (D) is localized to or compartmentalized near the membrane. The
presence of RTP1 (B) or REEP1 (B-C) appears to shift some TRPC2 immunoreactivity towards the membrane while that in the presence of
REEP1 (C) remains more cytosolic or intermediate. Immunoreactivity is
abolished in a vector-only transfection in E (pcDNA3). Horizontal scale
bar = 10 μm. Vertical scale bar = 50 arbitrary units. (A-E) = Z-series
stacked confocal image; (A'-E') = Representative single optical slice in
the midline; (A''-E'') = Intensity profiles quantified as a line scan taken
at the horizontal bar in A'-E'.

transfection efficiency for each condition, respectively
(Fig. 4I). TRPC2 transfection by itself (Figs. 4A and 4B)
and in conjunction with either RTP1 (Figs. 4C and 4D) or
REEP1 (Figs. 4E and 4F) resulted in an efficiency near
30% (Fig. 4I). Transfection with another myc-epitope
tagged six transmembrane spanning ion channel (Kv1.3)
was used as a positive control (Figs. 4G-H). The TRPC2
transfection condition efficiencies were significantly
below that of the positive control as measured by a one-

Figure 6 TRPC2 cell-surface biotinylation. Representative Western
blot of TRPC2-biotinylated protein following 48 hours after transfection of indicated cDNAs in HEK293s. (A) (Top panel) Biotinylated protein products (see methods) were precipitated with streptavidin
agarose beads, subjected to SDS-PAGE, and then probed with α-c-myc
(1:400) to visualize myc-Kv1.3 expression (far left lane) versus that of
mycTRPC2 expression under various transfection conditions. (Bottom
panel) Lysate input probed with α-β-actin. (B) Histogram plot of the
mean ± s.e.m. pixel immunodensity normalized to that of the TRP
alone condition. Transfection sample size noted. *= Mean pixel density
is statistically-different from channel only transfection; Dunnett's posthoc test, p ≤ 0.05. (C) Ratio of the expression levels of mycTRPC2 and
the internal standard, myc protein. Values are normalized against the
channel only condition.
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sought to visualize the effect of these chaperones on the
subcellular distribution of TRPC2 in the HEK293 cells.
The identical transfection scheme as in Fig. 4 was
repeated but high-resolution images of the labelled cells
were acquired using confocal microscopy. The results of
three such experiments are shown in Fig. 5. When
expressed alone, TRPC2 immunoreactivity is visualized
either near the nucleus (light blue; Fig. 5A) or in dense
patches seemingly away from the surface membrane
(bright green) and more easily viewed in an unstacked
image (Fig. 5A'). In contrast, Kv1.3 immunoreactivity is
visualized primarily at the surface membrane (Fig. 5D,
5D') and is known to insert into the surface membrane in
large numbers in HEK293 cells. Interestingly, co-expression with RTP1 (Fig. 5B, 5B') results in immunoreactivity
that is more typical of surface expression, with less
immunoreactivity near the nucleus (ie less light blue),
than that observed for the TRPC2 alone condition. Cotransfection with REEP1 results in an intermediate distribution (Fig. 5C, 5C'). Transfection of HEK293 cells with
TRPC2 and both chaperones did not appear different
than that of cells using transfection conditions with only
one chaperone in conjunction with TRPC2 (data not
shown). Cells labelled without the primary antiserum
were not immunoreactive (Fig. 5E, 5E'). Line plots of each
transfection condition in Fig. 5A-E demonstrate the αmyc immunoreactivity distribution.
To biochemically confirm the suggested increase in surface expression of TRPC2 by RTP1 and REEP1, a set of
cell-surface biotinylation experiments were conducted on
HEK293 cells transfected as in Fig. 5. The biotinylated
surface proteins were collected and processed by SDSPAGE and visualized via Western analysis using an antiserum to the myc-epitope. Cell lysates were also processed by SDS-PAGE and visualized via Western analysis
for β-actin to confirm equivalent protein loading. A representative Western blot of biotinylated TRPC2 channel
is reported in Fig. 6 as quantified 48 hrs following transfection in register with subsequent functional physiological experiments below. RTP1, but not REEP1,
significantly increased TRPC2 surface biotinylation (Significantly-different mean pixel density; one-way ANOVA
followed by a Dunnett's post-hoc test F = 4.1, p < 0.05;
Fig. 6B). When transfected alone, surface TRPC2 was
detected in only 2 out of 7 trials; while when transfected
with RTP1, surface TRPC2 was detected in 7 out of 7 trials. Comparatively, myc-tagged Kv1.3 was strongly
detected under either condition (Fig. 6A).
Cell-surface TRPC2 is functionally detected

To confirm that the cell-surface expressed TRPC2 was
functional, a set of whole-cell electrophysiological experiments were conducted on HEK293 cells transfected as in
Fig. 5. Dynabead technology using co-transfection of the
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channel with CD8 was employed to pan for transfected
cells appropriate for whole-cell patch-clamp (see methods for details). Transfected HEK293 cells that were
lightly beaded (2-4 beads) and apparently exiting mitosis
were targeted in order to facilitate the generation of consistent, comparable recordings across several transfections. Cells were stimulated with a voltage-ramp protocol
as described in [9] and graphically displayed in Fig. 7A.
The total duration of the ramp was 140 ms with an interpulse interval of 60 s. Three to five ramp pulses were
applied to determine baseline current and then the
recording bath was changed (see methods) to yield a final
ATP concentration of 166 μM. Although diacylglycerol
(DAG) has been reported to activate endogenous TRPC2
channels in mouse VSNs [9], in our hands neither DAG
nor a synthetic analogue, OAG, was effective in gating
TRPC2 current in vertebrate VSNs [14]. We therefore
relied upon reported augmentation of TRPC2 via activation of purinergic current [24] as the metric of a functional assay of our in vitro system. Current at the end of
the voltage-ramp protocol (-80 mV) was used as a measure of response to ATP stimulation. As shown in Fig. 7C,
cells transfected with both TRPC2 and RTP1 elicited an
increase in ATP-evoked whole-cell current compared to
that of control cells that were transfected, but beadless
(Fig. 7A) or TRPC2-transfected only cells (Fig. 7B) (Significantly-different mean current; one-way ANOVA followed by a snk post-hoc test F = 7.68, p < 0.05; Fig. 7E).
Additionally, a different population of heavily-beaded
cells (N = 7) were observed, which had much larger voltage-activated current amplitudes that ranged from 400 to
4400 pA (mean = 1550 pA). These cells were minimally
responsive to ATP (Fig. 7D, E) and were only observed in
dishes transfected with both TRPC2 and RTP1.

Discussion
These experiments demonstrate that the putative olfactory receptor chaperone RTP1 interacts with not only
proteins of the GPCR superfamily, but also with ion channels. This novel finding was demonstrated in vivo by a
protein-protein interaction between TRPC2 and RTP1,
and in vitro by a RTP1-dependent increase in TRPC2 surface expression. An ion channel complex consisting of
TRPC2, Homer, and IP3R3 may exist in vivo. Our biochemical experiments indicate that TRPC2, the scaffold
protein Homer 1b/c, and the ion channel IP3R3 form protein-protein interactions in the native VNO. To the best
of our knowledge, an interaction between Homer and
TRPC2 has not been demonstrated in any sensory system. Lastly, our data represent the first characterization
of Homer expression in the rat VNO.
Homers are widely expressed in both the male and
female rat including, but not limited to, many brain
regions and the testes. Although these biochemical data
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Figure 7 Whole-cell electrophysiology. (A-D) Human embryonic kidney 293 (HEK293) cells were transiently transfected with cDNAs encoding the
TRPC2 channel, hCD8 and with or without RTP1 as noted. HEK293 cells were voltage-clamped at -60 mV in the whole-cell configuration and then a
ramp was applied (+80 to -80 mV; see methods) under control (black) and subsequent to ATP bath application (red). (A) Representative control (beadless) whole-cell recording. The bottom recordings are of the entire voltage protocol. The box outlines the portions of these recordings shown in
greater detail in the inset above the dashed lines and used in C-D. Representative recordings from the TRPC2 alone (B), TRPC2+ RTP1+ (C), and the
heavily beaded TRPC2+ RTP1+ (D) conditions. (E) Graph of the change in mean (± s.e.m) current at -80 mV following ATP stimulation as compared to
a previous stimulation under various transfection conditions as in (A-C). Solid black triangle = denotes the mean response to ATP stimulation by heavily beaded cells as in (D). Transfection sample size as noted. * = denotes mean current is statistically different from control transfection; ** = denotes
mean current is statistically different from TRPC2 transfection; one-way ANOVA followed by a snk post-hoc test (p ≤ 0.05). The voltage-ramp protocol
is described graphically in (A).

cannot exclusively rule out the possibility of Homer
expression in non-sensory regions, Homers are typically
associated with either post-synaptic membranes
[20,22,28-30,21,31]or membranes involved in calcium

signalling [19]. The VNO lysates used in these experiments contained both of these subcellular elements, consistent with previous expression patterns for Homer. The
non-sensory portions of the VNO are densely innervated
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Figure 8 Schematic of the hypothetical vomeronasal organ transduction model. The vomeronasal organ (VNO) signal transduction pathway begins at either a type 1 vomeronasal (V1R) or type 2 vomeronasal (V2R) G-protein coupled receptor (GPCR); V2Rs may be associated with a member of
the M10 major histocompatibility protein family. Upon pheromone binding, the V1R/V2R activates a guanidine trisphosphate-binding protein (G-protein). The activated G-protein stimulates the cleavage of phosphatidylinositol 4,5-bisphosphate (PIP2) into 1,4,5-inositol trisphosphate (IP3) and diacylglycerol (DAG) via phospholipase C (PLC). DAG has been reported to gate the non-specific cation current through the type 2 canonical transient
receptor potential channel (TRPC2). Although binding of IP3 to the IP3 receptor (IP3R) is not supported to yield a transduction current alone, two isoforms of IP3R (IP3R2 and IP3R3) are expressed in the VNO, and IP3R3 forms a complex with TRPC2. Whether or not ligand occupancy is required, inhibition of complex formation blocks chemosignal-activated current. TRPC2 expression is increased in the VSN microvillar membrane with the assistance
of the chaperone receptor transporting protein 1 (RTP1), whereby the channel associates with both Homer 1b/c and IP3R3. A calcium activated nonselective ion channel (CaNS) can amplify the chemosignal-induced current following the rise in intracellular calcium. This rise in intracellular calcium
also actives calcium-activated big conductance potassium ion channels (BK) as well as calmodulin (CaM), which may bind to both IP3R3 and TRPC2.

by the autonomic nervous system [3,32] and the sensory
microvilli contain a well-explored calcium-signalling
pathway (Fig. 8) [1,14,18]. Homer isoforms expressed in
the VNO could function similarly in smooth muscle cells
and in chemosensory signal transduction. Unlike mouse
data reported by [33], we do not find Homer 2 expression
in the rat VNO. Overall, we detected neither a sex difference in VNO expression of Homer 1b/c and 3 isforms nor
an appreciable amount of the Homer 2 isoform.
Our data demonstrating transcription of RTP1 and
REEP1 in the rat VNO support the previous finding of
these transcripts in the mouse VNO [25]. The fact that
our immunocytochemical characterization supports the
detection of RTP1 protein in olfactory sensory neuron
cilia, VSN microvilli, goblet cells and in the soft-palate
while RTP1 is not detected in the non-sensory respiratory epithelium, may provide important clues as to function. In vitro experiments support RTP1 interactions with

GPCRs associated with either odorant [25] or taste receptor families [34]. Similar protein-protein interactions
have not been found, however, with VRs [25].
Alternatively, MHC class 1b proteins have been found
to associate with the V2Rs and thus may not function
with TRPC2 [35,36]. Allowing for several different protein associations including M10-VR, RTP1-TRPC2, and
Homer-TRPC2-IP3R3 provides the pheromone transduction cascade with multiple regulatory sites (Fig. 8).
The immunoprecipitation data indicate that Homer is
not expressed in the non-sensory areas of the VNO,
rather it is expressed in VSN microvilli. Other data have
indicated that TRPC channels can interact with Homer
proteins [16]. For example, TRP (the drosophila homologue of TRPC [37]) is involved in such interactions in the
invertebrate photoreceptor [17]. Functionally, Homer
expression in the VSN would allow for receptor and
channel modulation. Linking TRPC2 and IP3R3 via
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Homer 1 would ensure high-fidelity transmission of the
calcium signal that flows through the open TRPC2 channel during chemosignal detection. Homer 3 does not
form protein-protein interactions with TRPC2 [16]. The
inducible form of Homer (1a isoform) was not detected in
the rat VNO. This short form lacks the coiled-coiled
domain and would oppositely be predicted to disassemble a TRPC2-Homer 1-IP3R3 complex (see Fig. 8). Disruption of this interaction could alter TRPC2 activity in a
manner similar to Homer 1a modulation of mGluR activity [21]. In previous VSN recordings, disruption of the
interaction between TRPC2 and IP3R3 resulted in a
diminished chemosignal response [14]. On the other
hand, TRPC1 mutants lacking Homer binding sites
formed spontaneously active channels when expressed in
vitro [16] and gene-targeted deletion of Homer 1
increased TRPC1 activity in vivo [16,38]. Thus, Homer 1
could provide the VSN signalling apparatus with flexibility in responding to and adapting to chemosignals. The
interaction between TRPC2 and RTP1 could provide further regulation of TRPC2 and the response of VSNs to
chemosignals, by modulation of total TRPC2 activity
dependent upon surface expression driven by the chaperone. The recognition sequence for RTP1 binding will
need to be investigated in future experiments.
The plasmid containing TRPC2-C14 had a low transfection efficiency in HEK293 cells. Transient transfection
of a plasmid containing Kv1.3 produces an efficiency percentage of approximately 60% [39], whereas TRPC2 efficiency is only about 30%. Poor transfection efficiencies
have been noted of some constructs using polycationic
transfection reagents [40]; however, other researchers
have tried alternative transient transfection methods with
TRPC2 and reported comparably low efficiencies [23,41].
It is interesting to speculate that the low transfection efficiency might be a result of apoptosis due to calcium cytotoxicity associated with spontaneously active TRPC2
channels. At least one other TRPC channel, TRPC4, has
been demonstrated to be spontaneously active in
HEK293 cells [42]. In light of the facts that neither chaperone increased TRPC2 transfection efficiency nor did
this efficiency match that of Kv1.3, a structurally similar
channel [43], suggests that proper TRPC2 cellular distribution and function may require binding partners not
present in our experiments. Lastly, RTP1 and REEP1 do
not appear to be toxic to the HEK293 cells, as transfection efficiency did not decrease with their expression.
RTP1 and REEP1 appear to alter the sub-cellular distribution of TRPC2 in vitro. In HEK293 cells, TRPC2
immunolabeling is predominately in large deposits that
are presumably vesicles, as imaged with laser confocal
microscopy. Although every transfection condition with
TRPC2 led to vesicular immunolabeling, the presence of
either RTP1 or REEP1 seemed to shift expression of the
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channel toward the surface membrane. These data indicate a functional relationship for the RTP1-TRPC2 coimmunoprecipitation found in VNO tissue. Our data
cannot distinguish the mechanism of TRPC2 surface
expression, which could be the result of either increased
TRPC2 inserted or inhibition of TRPC2 internalization.
Demonstration of robust Kv1.3 surface expression
lends credence to the assumptions made earlier when
comparing sub-cellular localization of TRPC2 in different
transfection conditions. Namely, when transfected with
chaperone, the TRPC2 immunolabeling signal was similar to the Kv1.3 immunolabeling in terms of subcellular
distribution. A similar shift in the immunolabeling signal
of olfactory receptors occurs when these receptors are
expressed in vitro with RTP or REEP [25] and with unrelated GPCRs [44]. It then follows that with the addition of
chaperone, more TRPC2 is in the surface membrane. In
support of this notion, in each transfection condition
where TRPC2 and RTP1 were transfected together,
TRPC2 was detected in the surface membrane. When
expressed alone, TRPC2 was infrequently detected in the
surface membrane. Increased TRPC2 surface expression
was detected with both cell-surface biotinylation and
with whole-cell electrophysiology.
The endogenous metabotropic ATP receptor pathway
utilized in our experiments to investigate in vitro TRPC2
current is similar to the VNO sensory transduction pathway as each activates PLC (Fig. 8) [24,45,46]. The electrophysiological data indicate that the surface expressed
TRPC2 is functional and able to respond to a signal transduction pathway similar to that present in the VNO. That
heavily-beaded, and presumably highly expressing,
TRPC2+ RTP1+ cells were minimally responsive to purinergic stimulation is not unexpected. TRPC3, another
TRPC channel, gains and loses agonist-induced activity
based on expression level [47]. Alternatively, the TRPC2
protein level may have been high enough and the purinergic receptor protein level low enough, that any interaction between the two might be negligible due to
stoichiometric limitations.
Regardless of the mechanism, these data suggest that
the half-life residence of TRPC2 in the membrane is
increased in the presence of RTP1. These results may
indicate that the functional interaction between RTP1
and TRPC2 is one of membrane stabilization rather than
trafficking. This is a different functional role for RTP1
from previously described [25] and is speculative. With
both olfactory and gustatory GPCRs, RTP1 is presumed
to traffic its target to the surface membrane [25,34].
Based upon our current results in the context of current knowledge [1,48,49], we propose the following
model (Fig. 8). A chemosignal binds to either VR-type
GPCR, activation of which ultimately results in a TRPC2dependent calcium influx across the surface membrane.
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Calcium can also enter the cytosol from the endoplasmic
reticulum via IP3R3. Homer 1 binding at either TRPC2
terminus [50] (residues 303PPTLL and 953LPVPF) may
alter the channel function. TRPC2 and mGluRs are both
integral transmembrane proteins and, therefore, the
known interactions of mGluR/IP3R [28] could be
replaced by TRPC2/IP3R complex formation in the VNO.
For example, Homer 1 may cluster IP3R3 to TRPC2 using
Homer binding motifs (PPXF, PPXXF and LPSSP) on
both channels in a similar fashion that Homers cluster
IP3R3 to mGluR [51]. This would be advantageous for at
least two reasons. First, the products of phospholipase C
hydrolysis of PIP2, IP3 and DAG, gate both IP3R3 and
TRPC2. Maintaining close proximity of the second-messenger targets would increase the speed of the signalling
cascade and decrease the amount of second-messenger
lost due to errant diffusion. Second, as IP3R3 may adopt a
conformation that favors opening upon calcium binding
[52], tethering IP3R3 next to the calcium source would
increase the speed of the signalling cascade. By tethering
IP3R3 underneath TRPC2, Homer would be expected to
increase the open probability of IP3R3 using calcium
influx contributed through the surface channel TRPC2.
Thus, Homer could both increase the speed and the efficiency of the TRPC2 signalling cascade as it does for
mGluR cascades. Signal adaptation is likely to come from
calcium-calmodulin inhibition of both IP3R3 [53] and
TRPC2 [54], calcium-activated big conductance potassium channels (BK) [55,56] and metabolism of DAG into
the lipid arachidonic acid [56,57].
Although complexes of channels and adaptors have
been found in the visual system, Homer is a relatively
newly discovered protein, and appears to be involved in
scaffolding, targeting, and localization. Our previous
finding of a direct protein-protein interaction between
IP3R3 and TRPC2 in the VNO neither ruled out an additional role for scaffolding proteins, such as the Homer
family, nor a role for chaperones, such as REEP1 and
RTP1. In fact, the addition of chaperones and the formation of an adaptor complex may be critical to channel
function and eagerly warrants future experimentation.

Conclusions
The VNO expresses members of the Homer protein family. TRPC2 complexes with both IP3R3 and Homer1b/c in
vivo in the VNO. RTP1 is expressed in the VNO, co-localizes with other members of the VNO transduction pathway and may be a member of the transduction pathway as
it forms a protein-protein interaction with TRPC2 in
vivo. In vitro, RTP1 appears to function as a chaperone of
TRPC2, increasing the amount of functional channel in
the surface membrane.
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Methods
Animal care and maintenance

Postnatal Day 30 (P30) Sprague-Dawley rats were used
for biochemistry experiments and were housed on a 12
h:12 h light:dark cycle in the Florida State University
(FSU) vivarium. All procedures were performed in accordance with the FSU Animal Care and Use Committee and
NIH-approved guidelines.
Solutions

Solutions used for protein sample or tissue preparation,
including phosphate buffered saline (PBS), lysis buffer
(LB), wash buffer (WB), and protease and phosphatase
inhibitor solution (PPI), were made as described in [58].
Tissue extract buffer (TEB) was prepared as in [22]. Cellsurface biotinylation solutions, including biotinylation
lysis buffer and biotinylation quench buffer, were made as
described by [59]. Immunoblot stripping buffers, including tris stripping buffer (TSB) and sodium citrate stripping buffer (SCSB), were also made as described in Colley
et. al. (2007). Electrophysiology solutions were prepared
as in [24] and were as follows (in mM): intracellular
pipette 150 KCl, 10 HEPES pH 7.2, 2 MgCl2, 10 glucose;
extracellular bath 140 NaCl2, 10 HEPES pH 7.4, 4 KCl, 4
CaCl2, 1 MgCl2, and 10 glucose. All chemicals were
obtained from either Sigma Chemical Company (St.
Louis, MO, USA) or Fisher Scientific (Suwanne, GA,
USA).
Plasmids and antibodies

All encoded cDNAs were downstream from a cytomegalovirus (CMV) promoter. TRPC2 clone 14, with an N-terminal myc-epitope (EQKLISEEDL), was prepared in the
pcDNA3 vector and was a kind gift from Dr. L Birnbaumer (National Institute of Environmental Health Sciences) [10]. RTP1 and REEP1 were in the pCI vector and
were kind gifts of Dr. H. Matsunami (Duke University)
[25]. pCDM8 was a kind gift from Dr. Brian Seed (Harvard University) [60]. DNA encoding human CD8 was
amplified from pCDM8 and subcloned into the pcDNA3
vector (Carlsbad, CA, Invitrogen) between the BamH1
and EcoR1 restriction sites. cDNA encoding Kv1.3 was
subcloned into the pcDNA3 vector (Carlsbad, CA, Invitrogen) at the unique HindIII restriction site within the
multiple cloning region [39]. Kv1.3 was also epitopetagged via insertion of the myc sequence on the extracellular face of the channel between the S1 and S2 transmembrane domains [58].
T1NH, T2NH, and T3NH are anti-peptide polyclonal
antibodies specific for the type-1, -2 and -3 IP3R isoforms, respectively, and were raised against the following
amino terminal sequences (amino acid position in parentheses): T1NH = CLATGHYLAAEVDPDQEVDPDQ-
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DASR (308-326), T2NH = CPDYRDAQNEGKTVRDGKTVRDGELP (320-338) and T3NH = CENPSYKGDVSDPGDVSDPKAAGPGA (319-337). These antibodies were
a generous gift of Dr Gregory Mignery (Loyola University
Chicago, Stritch College of Medicine, Maywood, IL,
USA) [61]. An antiserum detecting TRPC2 as raised in
guinea pig and directed against the N-terminal cytosolic
domain CSSDASGAGPGGPLRNVE was a generous gift
of Dr. Richard Axel (Columbia University, New York, NY,
USA) [12]. Anti-peptide polyclonal antibodies detecting
the different forms of Homer were made by immunizing
rabbits with the synthetic C-terminal peptides of Homer
1b/c (IFELTELRDNLAKLLECS), 2a/b (GKIDDLHDFRRGLSKLGTDN), or 3 (RLFELSELRE-GLARLAEAA)
conjugated to thyroglobulin with glutaraldehyde [22]. A
fourth, rabbit polyclonal antiserum recognizing all
Homer 1 (1a, 1b, and 1c) isoforms was generated against
the full-length GST-Homer 1a fusion protein [20]. These
antibodies were a generous gift of Dr. Paul Worley (Johns
Hopkins University, Baltimore, MD, USA). A polyclonal
antibody recognizing all Homer proteins (Pan-Homer;
1a, 1b, 1c, 2a, 2b, 3) was made by immunizing rats with
recombinant Homer 1a (AB5875, Chemicon/Millipore,
St. Louis, MO, USA). The mouse monoclonal antiserum
for the c-myc epitope was from Roche (Indianapolis, IN,
USA). Rabbit polyclonal antiserum specific to RTP1 was a
kind gift of Dr. Hiro Matsunami (Duke University, Durham, NC, USA) [62]. When necessary to validate equal
protein loading, a rabbit polyclonal antibody detecting
cellular actin was used. The immunogen for this antibody
was SGPSIVHRKCF attached to a Multiple Antigen Peptide (MAP) backbone (Sigma Chemical).
Tissue homogenization and Western blotting

Tissue extracts were prepared as in [22]. Briefly, P30 rats
were killed by CO2 inhalation, decapitated, and VNOs
were rapidly dissected and placed in ice cold TEB with
PPI. Samples on ice were sonicated (Sonic Dismembrator,
Model 60, Fisher Scientific) twice for eight seconds on
setting number five. Non-soluble matter was removed by
ultracentrifugation (Beckman Coulter, Fullerton, CA,
USA) at 37,000 × g for 30 min at 4°C. The supernatant
was aliquoted and stored at -80°C until use. The resultant
pellet was solubilized in 2% sodium dodecyl sulfate
(SDS), aliquoted, and stored at -80°C in case the initial
screening of the lysates did not yield membrane-associated fractions.
Immunoprecipitations were performed as in [18]. In
brief, P30 rat VNOs were homogenized with a size 20
Kontes glass tissue-homogenizer (Kontes Glass,
Vineland, NJ, USA) on ice in LB with PPI. Lysis was continued on a Roto-Torque (Model 7637, Cole-Parmer
Instruments, Vernon Hills, IL, USA) for 30 min at 4°C.
Lysates were clarified by centrifugation at 15,000 × g
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(Eppendorf, Model 5415C, Westbury, NY, USA) for 10
min at 4°C and then precleared for 1 hour (hr) with 3 mg/
ml protein A sepharose (GE Healthcare, Uppsalla). This
was followed by another centrifugation step to remove
the protein A sepharose. Proteins of interest (Homer 1b/
c, Homer 2, Homer 3, TRPC2, IP3R3, RTP1) were immunoprecipitated from the clarified lysates by overnight
incubation on a Roto-Torque at 4°C with 5 μg/ml of
appropriate antiserum. Samples were then incubated for
3 hr with protein A sepharose and centrifuged as above.
Immunoprecipitates were washed four times with 5 volumes of WB. Lysates and washed immunoprecipitates
were diluted in SDS gel loading buffer containing [63] 1
mM Na3VO4 and stored at -20°C until use.
Purified VNO tissue extracts or immunoprecipitated
proteins were separated on 6 to 15% acrylamide gels by
SDS-PAGE and electro-transferred to nitrocellulose
membranes. Equal protein loading (30 μg) was controlled
by Bradford protein assay (BioRad, Hercules, CA, USA)
and confirmed by 0.1% Fast Green staining and α-β-actin
labeling. The nitrocellulose membrane was blocked with
5% non-fat milk for 60 min, incubated overnight at 4°C in
primary antisera against TRPC2 (1:2000), IP3R3 (1:2000),
RTP1 (1:1000), Homer 1b/c (1:1000), Homer 2a/b
(1:2000), Homer 3 (1:2000), Homer 1 isoforms (Worley,
1:1000), all Homer isoforms (Chemicon, 1:1000), or RTP1
(1:1000). Membranes were then incubated with horseradish peroxidase-conjugated species-specific secondary
antibody (donkey anti-rabbit, Amersham Biosciences or
rabbit anti-guinea pig, Sigma) for 90 min at room temperature (rt). Labelled protein was detected with enhanced
chemiluminescence (ECL; Amersham Biosciences, Piscataway, NJ, USA) using Classic Blue autoradiography
film BX (MidSci, St. Louis, MO, USA). To ensure equal
loading, nitrocellulose membranes were stripped by incubating blots in eight ten-minute washes of TSB, followed
by eight ten-minute washes of SCSB, then re-probed
using α-β-actin (1:1000). Autoradiographs were scanned
using a Hewlett-Packard Photosmart Scanner (Model
106-816; Hewlett-Packard, San Diego, CA, USA) and
quantified by line scanning densitometry using Quantiscan Software (Biosoft, Cambridge, UK).
RNA extraction and reverse-transcriptase PCR

P30 rats were killed by CO2 inhalation, decapitated, and
VNOs were rapidly dissected from the surrounding tissues and placed on dry ice. RNA was extracted using the
SV Total RNA Isolation System as per the manufacturer's
protocol (Promega, Madison, WI, USA). RNA purity and
concentration was determined by UV spectroscopy (NanoDrop-1000, Wilmington, DE, USA). cDNA was reversetranscribed using the ImPromII kit as per manufacturer's
protocol (Promega). Gene-specific primers have been
previously reported [34] and were as follows:
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RTP1_forward, AAGCGTGACCACAGATGAGTG; RT
P1_reverse, GAGCAGAAGTTCCAGCCTGAG; REEP1_
forward, CAATGAATTCCCACCATGGTGTCATGGA
TCATCTCCAGGC; REEP1_reverse, GACTAGCGGCCGCCTAGGCGGTGCCTGAGCTGCTAG. PCR products were resolved using 1.0% agarose gel electrophoresis
and visualized via UV excitation of the incorporated
ethidium bromide.
Human embryonic kidney cell (HEK293) maintenance and
transfection

HEK 293 cells were maintained in minimum essential
medium (MEM), 2% penicillin/streptomycin, and 10%
FBS (Gibco BRL). Before transfection, cells were grown to
confluence (~7 days), dissociated with trypsin, and replated to low density onto Corning substrate-coated plasticware on poly-d-lysine-treated glass coverslips as previously described [39]. HEK293 cells were transfected for
4-5 hrs at 37°C with plasmid cDNA and LipofectamineTM transfection reagent (Invitrogen, Carlsbad,
CA, USA) in OptiMEM serum-reduced media (Gibco
BRL). Either 1.5 μg of plasmid DNA and 7.5 μl Lipofectamine were applied to 30-50% confluent glass coverslips in 35 mm dishes or 3.0 μg of plasmid DNA and 15 μl
Lipofectamine were applied to 80-95% confluent 60 mm
dishes, for immunocytochemical and biochemical experiments, respectively. pcDNA3 vector was used to normalize total DNA concentration in co-transfection
conditions, as previously [64].
Immunocytochemistry

Thirty-six hrs post-transfection, HEK293 cells were
washed in PBS and fixed in ice-cold St. Marie's fixative
(1.0% acetic acid in 95% ethanol). Cells were washed three
times in PBS and incubated for 30 min at rt in PBSTblock (0.1% Triton x-100 in PBS and 1% Bovine Serum
Albumin). Cells were immunolabeled with primary antisera diluted in PBST-block for 90 min at rt or overnight at
4°C with α-c-myc. Cells were then washed three times in
PBS. The secondary antisera were applied at rt for 1.5 hr
in PBS using fluorescein isothiocyanate-conjugated goat
anti-mouse antiserum (1:200). Following three washes in
PBS, cells were counter-stained with a five-minute incubation in diamidino-phenyindole (DAPI) in PBS (1:5000).
The cells were mounted on glass slides with Vectashield
(Vector Laboratories, Burlingame, CA, USA) to prevent
photobleaching.
Tissue sections (~16 μm) were prepared from P30 rats
that had been fixed-perfused (4% paraformaldehyde) and
sucrose cryoprotected as previously described [18]. Sections were air-dried on the bench for 60 minutes, rehydrated with PBS, and then incubated at 80°C in 10 mM
sodium citrate for 30 minutes for antigen retrieval [65].
The sections were cooled and non-specific binding was
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blocked by a 60-minute incubation in blocking solution
(5% normal goat serum/2.5% BSA/0.3% triton in PBS).
During the block, the primary antibodies were treated
with L-glutathione to cap reactive SH-functional groups.
On ice, an L-glutathione/Tris-EDTA solution was diluted
in the blocking solution containing the primary antiserum to a final concentration of 30 mM L-glutathione
Tris-EDTA/1.25% normal goat serum/0.625% BSA/
0.075% triton [66]. After the block, sections were rinsed
with Tris-EDTA - 0.3% triton and incubated with antiserum overnight in a darkened, humidified chamber. Antiserum for RTP1 was used at a final dilution of 1:200 and
antisera for TRPC2 was used at 1:400. Sections to be
stained using the ABC method were treated according to
the manufacturer's protocol (Vector, Burlingham, CA,
USA) and the precipitate was visualized with the chromagen AEC (Sigma). Immunofluorescence was detected
with either donkey anti-rabbit Texas Red (Amersham
Biosciences) or rabbit anti-guinea pig FITC (Sigma).
Microscopy

Conventional light microscopy was performed on an
Axiovert S-100 (Zeiss, Thornwood, NY, USA) equipped
with epifluoresence, an AxioCam camera (#412-312,
Zeiss), and Axiovision data capture software (version 3.1,
Zeiss). Images were captured with a pixel resolution of
1300 × 1030. Laser confocal microscopy was performed
on an Axioplan 2 microscope attached to an LSM510
two-confocal system (Zeiss). FITC was excited at 488 and
DAPI at 700 nm with argon/2 and titanium/sapphire
lasers, respectively. Images were captured at 1024 × 1024
pixels resolution in LSM file format, and then were converted to a 16-bit TIFF file format using LsMB software
(Zeiss). The TIFF file was opened in NIH ImageJ http://
rsb.info.nih.gov/ij/ and a uniform rectangle of 200 pixels
× 20 pixels was applied across the center of the cell (Zaxis) to obtain the plot density profile of the pixels underneath, as previously described [67].
Transfection efficiency analysis

Three to nine fields of view for each transfection condition (TRPC2 + pcDNA3, TRPC2 + RTP1, TRPC2 +
REEP1, and Kv1.3 + pcDNA3) were captured under a fluorescent and either a brightfield or a DAPI emission.
Each field of view was approximately 90,000 μm2. Transfection efficiency was calculated for each field of view as
the ratio of the number of fluorescent cells divided by the
total number of cells. Cell counts were performed using
NIH ImageJ software.
Cell-surface biotinylation

Cell-surface biotinylation was performed as described
[59]. Briefly, either 24- or 48-hr post-transfection,
HEK293 cells were washed with ice-cold PBS and then
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incubated with 1.0 mg/ml biotin (Pierce, Rockford, Ill,
USA) in PBS for 30 min at 4°C. Following a PBS rinse,
cells were incubated for 30 min at 4°C in quench buffer,
rinsed again, and then lysed for 30 min at 4°C in lysis buffer. Lysed cells were scraped, triturated, and centrifuged
at 12,000 rpm for 10 min at 4°C. The supernatants were
collected and aliquots were set aside for confluency controls. Protein concentration was calculated using a Bradford assay (BioRad). Equal amounts of protein were
brought up to 1 ml with PBS (pH 8.0) and incubated overnight at 4°C with 40 μl streptavidin-conjugated agarosebeads (Pierce). The beads were pelleted with a centrifugation of 12,000 rpm for 10 min at 4°C, washed, and then
stored at -20°C until further use.
Whole-cell electrophysiology

Hoffman modulation contrast optics was used to visualize cells at 40× magnification (Axiovert 135, Carl Zeiss).
Thirty-six hrs post-transfection, HEK293 cells were
rinsed with bath solution and incubated with anti-hCD8
beads (Dyna-Beads, Invitrogen) to mark transfected cells
(either hCD8+/TRPC2+/RTP1- or cCD8+/TRPC2+/
RTP1+) [60]. Co-expression with CD8 allows visualization of cells taking up the cDNA encoding the channel or
receptor of interest by marking transfected cells with a
red polypropylene-antibody-linked bead. We [64] and
others [58] have demonstrated that single cells take up
multiple constructs equivalently and that the density of
the beads is proportional to the expression of channel of
interest. Cells were rinsed two times before beginning a
recording session to remove any unbound beads. Cells
were rinsed two more times before beginning a recording
session. Electrophysiological records were analyzed using
software from Microcal Origin (Northampton, MA) and
Quattro Pro (Borland International, Scotts Valley, CA).
Patch electrodes were fabricated from Jencons glass
(Jencons Limited, Bridgeville, PA) with pipette resistances between 9 and 14 MΩ. Macroscopic currents were
recorded in the whole-cell configuration using an Axopatch-200B amplifier (MDS Analytical Technologies/
Axon Instruments, Sunnyvale, CA), filtered at 5 kHz, digitized at 5 kHz, and stored for later analysis. All voltage
signals were generated and data were acquired with the
use of an Axon Digidata 1200 board with pClamp v9.2
software (Axon Instruments). Cells were held routinely at
a holding potential (Vh) of -60 mV, stepped to 80 mV (Vc),
held for 40 milliseconds (ms), and then changed to a
ramp protocol by falling to -80 mV over 100 ms (-1.6 mV/
ms). The total pulse duration was 140 ms and the inter
pulse interval was 60 seconds. Several sweeps were taken
over the 3-6 minutes after establishing the whole-cell
configuration to establish a stable baseline. ATP stimulation was achieved with bath application of 0.5 ml of 500
μM for a final bath concentration of ~166 mM ATP. Peak
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inward current amplitude was measured at -80 mV from
a subsequent sweep.
Data analysis

Numerical data were statistically analyzed using Prizm
software (version 4, GraphPad, San Diego, CA, USA).
One-way Analysis of Variance (ANOVA) with either a
Student-Newman-Keuls (snk) or a Dunnett's post-hoc
test was performed with statistical significance determined at the 95% confidence interval.

Additional material
Additional file 1 Fig. S1 - RTP1 Antiserum Characterization and Immunoprecipitation Controls. (A) NP40-solubilized samples of mouse main
olfactory epithelia (MOE), collected at noted postnatal (P) stages, were separated by SDS-PAGE and electro-transferred to nitrocellulose. RTP1 antiserum recognized the appropriate band (expected Mr = 25 kDa). The faint
band at the arrowhead may be an RTP1 variant described previously in the
MOE [62], but not observed in the VNO (Fig. 3). The top blot probed for the
RTP1 chaperone (RTP1) was stripped and reprobed for β-actin (Actin)(Mr =
42 kDa). (B-C) HEK293 cells transfected with the RTP1 expression vector
were incubated at 37° with either (B) PBS or (C) 200 μg/μl proteinase K. Cells
were immunolabelled with αRTP1 without detergent and processed for
RTP1 immunoreactivity as described previously [68]. Note the loss of RTP1
immunoreactivity in (C). (D) VNO lysates were used in immunoprecipitation
experiments as in Fig. 3, except non-immune rabbit sera was used as the
source of the first immunoglobulin. Note the loss of bands at the expected
Mr for TRPC2 97, IP3R3 >220, Homer 1b/c 45, and RTP1 25 kDa as indicated.
IgG = the heavy chain of the immunoglobin G.
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